Interaction of Cholera Toxin B-subunit with Human T-lymphocytes

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Cholera toxin B-subunit (CT-B) is a known ligand for certain cell surface receptors.
• Interferon-alpha2 (IFN-alpha2) and thymosin-alpha1 (TM-alpha1) are immunomodulatory proteins with potential receptor interactions.
• Guanylate cyclase enzymes play critical roles in cellular signaling pathways.

Purpose of the Study:

• To investigate the binding characteristics of 125I-labeled CT-B to human T-lymphocytes.
• To determine if IFN-alpha2, TM-alpha1, or related peptides compete for CT-B binding.
• To examine the effect of CT-B and a specific peptide on guanylate cyclase activity.

Main Methods:

• Preparation and characterization of 125I-labeled CT-B.
• Competitive binding assays using T-lymphocytes and various unlabeled ligands.
• Enzyme activity assays for soluble guanylate cyclase (sGC) and membrane-bound guanylate cyclase.

Main Results:

• 125I-labeled CT-B demonstrated high-affinity binding to human T-lymphocytes (Kd = 3.3 nM).
• Unlabeled IFN-alpha2, TM-alpha1, and the synthetic peptide LKEKK (a shared sequence) inhibited CT-B binding (Ki = 0.8-1.6 nM).
• CT-B and LKEKK peptide dose-dependently increased sGC activity, but not membrane-bound guanylate cyclase, while the inverted peptide KKEKL had no effect.

Conclusions:

• CT-B and the peptide LKEKK bind to a common receptor on T-lymphocytes.
• This binding event leads to the activation of soluble guanylate cyclase (sGC).
• The findings suggest a novel signaling pathway involving CT-B and specific peptides impacting T-lymphocyte function.